Detection of high-risk human papillomavirus infected cervical biopsies samples by immunohistochemical expression of the p16 tumor marker

Cervical cancer is the fourth most common type of cancer in women worldwide. It is widely accepted that the main cause of cervical cancer, especially in underdeveloped countries like Pakistan, is the infection caused by the human papillomavirus (HPV). The current screening and diagnostic methods fac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of microbiology 2024-01, Vol.206 (1), p.17-17, Article 17
Hauptverfasser: Shafique, Muhammad, Shoaib, Iqra, Aslam, Bilal, Khalid, Rabia, Tanvir, Imrana, Rasool, Muhammad Hidayat, Shah, Tawaf Ali, Almaary, Khalid S., Bourhia, Mohammed, Qamar, Muhammad Usman
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 17
container_issue 1
container_start_page 17
container_title Archives of microbiology
container_volume 206
creator Shafique, Muhammad
Shoaib, Iqra
Aslam, Bilal
Khalid, Rabia
Tanvir, Imrana
Rasool, Muhammad Hidayat
Shah, Tawaf Ali
Almaary, Khalid S.
Bourhia, Mohammed
Qamar, Muhammad Usman
description Cervical cancer is the fourth most common type of cancer in women worldwide. It is widely accepted that the main cause of cervical cancer, especially in underdeveloped countries like Pakistan, is the infection caused by the human papillomavirus (HPV). The current screening and diagnostic methods face several challenges in accurately detecting the various types of lesions caused by HPV. Therefore, the present study was conducted to assess the effectiveness of p16 immunohistochemistry (IHC) analysis as a diagnostic method in samples of cervical biopsies. One hundred cervical biopsy samples were obtained from female patients across various age groups (> 20– ≤ 30, > 31– ≤ 40, > 41– ≤ 50, > 51– ≤ 60 years). These samples were subsequently prepared for subsequent examination. All samples were analyzed using automated tissue processing followed by Hematoxylin and Eosin (H & E) staining, and p16 IHC tumour marker staining. The H & E slides showed changes in normal cervical tissues, while four cervical abnormalities were identified statistically significant using p16 marker including chronic cervicitis, nabothian cyst formation, cervical intraepithelial neoplasia, and cervical cancers ( P value 0.014). Furthermore, among females of different age groups (> 31– ≤ 40, > 41– ≤ 50, > 51– ≤ 60 years) were found statistically significant suffering from cervical cancer ( P value 0.04), HPV with cervical cancer ( P value 0.01), HPV with cervical intraepithelial neoplasia ( P value 0.01). Based on the available data, it can be inferred that the incorporation of the p16 tumor marker may be a valuable method for detecting high-risk HPV in cervical biopsies samples.
doi_str_mv 10.1007/s00203-023-03736-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3153568148</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2902934415</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-5b52a5ebca12de14b15706ea298309ea3c1408d07a80e5c5bcb7360c80b0b4763</originalsourceid><addsrcrecordid>eNqFkc9u1DAQhy0EosvCC3BAlrhwCYztOHGOqPyVKnEBiVtke2cbt3EcPElF34DHxttdQOIAB2sO_n4zHn-MPRXwUgC0rwhAgqpAlqNa1VRwj21ErWQFrfx6n21AgaxMp9QZe0R0BSCkMeYhO1MGjFY1bNiPN7igX0KaeNrzIVwOVQ50zYc12onPdg7jmKK9CXklHqZ9YXHHPeab4O3IXUgzBSRONs5jqe6WhxjXKQ2BluQHjHccfp8zEp3GLAPyWTR8WWPKPNp8jfkxe7C3I-GTU92yL-_efj7_UF18ev_x_PVF5WswS6Wdllaj81bIHYraCd1Cg1Z2RkGHVnlRuB201gBqr5135WfAG3Dg6rZRW_bi2HfO6duKtPQxkMdxtBOmlXoltNKNEbX5Lyo7kJ2q65LYsud_oVdpzVNZ5EBBW95QVG2ZPFI-J6KM-37Ooax_2wvoD0r7o9K-KO3vlPaH0LNT69VF3P2O_HJYAHUEqFxNl5j_zP5H25_Oa62N</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2900773620</pqid></control><display><type>article</type><title>Detection of high-risk human papillomavirus infected cervical biopsies samples by immunohistochemical expression of the p16 tumor marker</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Shafique, Muhammad ; Shoaib, Iqra ; Aslam, Bilal ; Khalid, Rabia ; Tanvir, Imrana ; Rasool, Muhammad Hidayat ; Shah, Tawaf Ali ; Almaary, Khalid S. ; Bourhia, Mohammed ; Qamar, Muhammad Usman</creator><creatorcontrib>Shafique, Muhammad ; Shoaib, Iqra ; Aslam, Bilal ; Khalid, Rabia ; Tanvir, Imrana ; Rasool, Muhammad Hidayat ; Shah, Tawaf Ali ; Almaary, Khalid S. ; Bourhia, Mohammed ; Qamar, Muhammad Usman</creatorcontrib><description>Cervical cancer is the fourth most common type of cancer in women worldwide. It is widely accepted that the main cause of cervical cancer, especially in underdeveloped countries like Pakistan, is the infection caused by the human papillomavirus (HPV). The current screening and diagnostic methods face several challenges in accurately detecting the various types of lesions caused by HPV. Therefore, the present study was conducted to assess the effectiveness of p16 immunohistochemistry (IHC) analysis as a diagnostic method in samples of cervical biopsies. One hundred cervical biopsy samples were obtained from female patients across various age groups (&gt; 20– ≤ 30, &gt; 31– ≤ 40, &gt; 41– ≤ 50, &gt; 51– ≤ 60 years). These samples were subsequently prepared for subsequent examination. All samples were analyzed using automated tissue processing followed by Hematoxylin and Eosin (H &amp; E) staining, and p16 IHC tumour marker staining. The H &amp; E slides showed changes in normal cervical tissues, while four cervical abnormalities were identified statistically significant using p16 marker including chronic cervicitis, nabothian cyst formation, cervical intraepithelial neoplasia, and cervical cancers ( P value 0.014). Furthermore, among females of different age groups (&gt; 31– ≤ 40, &gt; 41– ≤ 50, &gt; 51– ≤ 60 years) were found statistically significant suffering from cervical cancer ( P value 0.04), HPV with cervical cancer ( P value 0.01), HPV with cervical intraepithelial neoplasia ( P value 0.01). Based on the available data, it can be inferred that the incorporation of the p16 tumor marker may be a valuable method for detecting high-risk HPV in cervical biopsies samples.</description><identifier>ISSN: 0302-8933</identifier><identifier>EISSN: 1432-072X</identifier><identifier>DOI: 10.1007/s00203-023-03736-0</identifier><identifier>PMID: 38085340</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Abnormalities ; Adult ; Age groups ; automation ; Biochemistry ; Biomarkers ; Biomarkers, Tumor - analysis ; Biomarkers, Tumor - metabolism ; Biomedical and Life Sciences ; Biopsy ; Biotechnology ; Cancer ; Cell Biology ; Cervical cancer ; Cervicitis ; Developing countries ; Diagnostic systems ; diagnostic techniques ; Ecology ; eosin ; Female ; Females ; Human papillomavirus ; Human Papillomavirus Viruses ; Humans ; Immunohistochemistry ; LDCs ; Life Sciences ; Microbial Ecology ; Microbiology ; Middle Aged ; Original Paper ; Pakistan ; Papillomaviridae ; Papillomavirus Infections - diagnosis ; Papillomavirus Infections - pathology ; Samples ; Staining ; Statistical analysis ; Tumor markers ; Tumors ; Uterine Cervical Dysplasia - diagnosis ; Uterine Cervical Dysplasia - pathology ; uterine cervical neoplasms ; Uterine Cervical Neoplasms - diagnosis ; Uterine Cervical Neoplasms - pathology ; Young Adult</subject><ispartof>Archives of microbiology, 2024-01, Vol.206 (1), p.17-17, Article 17</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-5b52a5ebca12de14b15706ea298309ea3c1408d07a80e5c5bcb7360c80b0b4763</citedby><cites>FETCH-LOGICAL-c408t-5b52a5ebca12de14b15706ea298309ea3c1408d07a80e5c5bcb7360c80b0b4763</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00203-023-03736-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00203-023-03736-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38085340$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shafique, Muhammad</creatorcontrib><creatorcontrib>Shoaib, Iqra</creatorcontrib><creatorcontrib>Aslam, Bilal</creatorcontrib><creatorcontrib>Khalid, Rabia</creatorcontrib><creatorcontrib>Tanvir, Imrana</creatorcontrib><creatorcontrib>Rasool, Muhammad Hidayat</creatorcontrib><creatorcontrib>Shah, Tawaf Ali</creatorcontrib><creatorcontrib>Almaary, Khalid S.</creatorcontrib><creatorcontrib>Bourhia, Mohammed</creatorcontrib><creatorcontrib>Qamar, Muhammad Usman</creatorcontrib><title>Detection of high-risk human papillomavirus infected cervical biopsies samples by immunohistochemical expression of the p16 tumor marker</title><title>Archives of microbiology</title><addtitle>Arch Microbiol</addtitle><addtitle>Arch Microbiol</addtitle><description>Cervical cancer is the fourth most common type of cancer in women worldwide. It is widely accepted that the main cause of cervical cancer, especially in underdeveloped countries like Pakistan, is the infection caused by the human papillomavirus (HPV). The current screening and diagnostic methods face several challenges in accurately detecting the various types of lesions caused by HPV. Therefore, the present study was conducted to assess the effectiveness of p16 immunohistochemistry (IHC) analysis as a diagnostic method in samples of cervical biopsies. One hundred cervical biopsy samples were obtained from female patients across various age groups (&gt; 20– ≤ 30, &gt; 31– ≤ 40, &gt; 41– ≤ 50, &gt; 51– ≤ 60 years). These samples were subsequently prepared for subsequent examination. All samples were analyzed using automated tissue processing followed by Hematoxylin and Eosin (H &amp; E) staining, and p16 IHC tumour marker staining. The H &amp; E slides showed changes in normal cervical tissues, while four cervical abnormalities were identified statistically significant using p16 marker including chronic cervicitis, nabothian cyst formation, cervical intraepithelial neoplasia, and cervical cancers ( P value 0.014). Furthermore, among females of different age groups (&gt; 31– ≤ 40, &gt; 41– ≤ 50, &gt; 51– ≤ 60 years) were found statistically significant suffering from cervical cancer ( P value 0.04), HPV with cervical cancer ( P value 0.01), HPV with cervical intraepithelial neoplasia ( P value 0.01). Based on the available data, it can be inferred that the incorporation of the p16 tumor marker may be a valuable method for detecting high-risk HPV in cervical biopsies samples.</description><subject>Abnormalities</subject><subject>Adult</subject><subject>Age groups</subject><subject>automation</subject><subject>Biochemistry</subject><subject>Biomarkers</subject><subject>Biomarkers, Tumor - analysis</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Biomedical and Life Sciences</subject><subject>Biopsy</subject><subject>Biotechnology</subject><subject>Cancer</subject><subject>Cell Biology</subject><subject>Cervical cancer</subject><subject>Cervicitis</subject><subject>Developing countries</subject><subject>Diagnostic systems</subject><subject>diagnostic techniques</subject><subject>Ecology</subject><subject>eosin</subject><subject>Female</subject><subject>Females</subject><subject>Human papillomavirus</subject><subject>Human Papillomavirus Viruses</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>LDCs</subject><subject>Life Sciences</subject><subject>Microbial Ecology</subject><subject>Microbiology</subject><subject>Middle Aged</subject><subject>Original Paper</subject><subject>Pakistan</subject><subject>Papillomaviridae</subject><subject>Papillomavirus Infections - diagnosis</subject><subject>Papillomavirus Infections - pathology</subject><subject>Samples</subject><subject>Staining</subject><subject>Statistical analysis</subject><subject>Tumor markers</subject><subject>Tumors</subject><subject>Uterine Cervical Dysplasia - diagnosis</subject><subject>Uterine Cervical Dysplasia - pathology</subject><subject>uterine cervical neoplasms</subject><subject>Uterine Cervical Neoplasms - diagnosis</subject><subject>Uterine Cervical Neoplasms - pathology</subject><subject>Young Adult</subject><issn>0302-8933</issn><issn>1432-072X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkc9u1DAQhy0EosvCC3BAlrhwCYztOHGOqPyVKnEBiVtke2cbt3EcPElF34DHxttdQOIAB2sO_n4zHn-MPRXwUgC0rwhAgqpAlqNa1VRwj21ErWQFrfx6n21AgaxMp9QZe0R0BSCkMeYhO1MGjFY1bNiPN7igX0KaeNrzIVwOVQ50zYc12onPdg7jmKK9CXklHqZ9YXHHPeab4O3IXUgzBSRONs5jqe6WhxjXKQ2BluQHjHccfp8zEp3GLAPyWTR8WWPKPNp8jfkxe7C3I-GTU92yL-_efj7_UF18ev_x_PVF5WswS6Wdllaj81bIHYraCd1Cg1Z2RkGHVnlRuB201gBqr5135WfAG3Dg6rZRW_bi2HfO6duKtPQxkMdxtBOmlXoltNKNEbX5Lyo7kJ2q65LYsud_oVdpzVNZ5EBBW95QVG2ZPFI-J6KM-37Ooax_2wvoD0r7o9K-KO3vlPaH0LNT69VF3P2O_HJYAHUEqFxNl5j_zP5H25_Oa62N</recordid><startdate>20240101</startdate><enddate>20240101</enddate><creator>Shafique, Muhammad</creator><creator>Shoaib, Iqra</creator><creator>Aslam, Bilal</creator><creator>Khalid, Rabia</creator><creator>Tanvir, Imrana</creator><creator>Rasool, Muhammad Hidayat</creator><creator>Shah, Tawaf Ali</creator><creator>Almaary, Khalid S.</creator><creator>Bourhia, Mohammed</creator><creator>Qamar, Muhammad Usman</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>RC3</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope></search><sort><creationdate>20240101</creationdate><title>Detection of high-risk human papillomavirus infected cervical biopsies samples by immunohistochemical expression of the p16 tumor marker</title><author>Shafique, Muhammad ; Shoaib, Iqra ; Aslam, Bilal ; Khalid, Rabia ; Tanvir, Imrana ; Rasool, Muhammad Hidayat ; Shah, Tawaf Ali ; Almaary, Khalid S. ; Bourhia, Mohammed ; Qamar, Muhammad Usman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-5b52a5ebca12de14b15706ea298309ea3c1408d07a80e5c5bcb7360c80b0b4763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Abnormalities</topic><topic>Adult</topic><topic>Age groups</topic><topic>automation</topic><topic>Biochemistry</topic><topic>Biomarkers</topic><topic>Biomarkers, Tumor - analysis</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Biomedical and Life Sciences</topic><topic>Biopsy</topic><topic>Biotechnology</topic><topic>Cancer</topic><topic>Cell Biology</topic><topic>Cervical cancer</topic><topic>Cervicitis</topic><topic>Developing countries</topic><topic>Diagnostic systems</topic><topic>diagnostic techniques</topic><topic>Ecology</topic><topic>eosin</topic><topic>Female</topic><topic>Females</topic><topic>Human papillomavirus</topic><topic>Human Papillomavirus Viruses</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>LDCs</topic><topic>Life Sciences</topic><topic>Microbial Ecology</topic><topic>Microbiology</topic><topic>Middle Aged</topic><topic>Original Paper</topic><topic>Pakistan</topic><topic>Papillomaviridae</topic><topic>Papillomavirus Infections - diagnosis</topic><topic>Papillomavirus Infections - pathology</topic><topic>Samples</topic><topic>Staining</topic><topic>Statistical analysis</topic><topic>Tumor markers</topic><topic>Tumors</topic><topic>Uterine Cervical Dysplasia - diagnosis</topic><topic>Uterine Cervical Dysplasia - pathology</topic><topic>uterine cervical neoplasms</topic><topic>Uterine Cervical Neoplasms - diagnosis</topic><topic>Uterine Cervical Neoplasms - pathology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shafique, Muhammad</creatorcontrib><creatorcontrib>Shoaib, Iqra</creatorcontrib><creatorcontrib>Aslam, Bilal</creatorcontrib><creatorcontrib>Khalid, Rabia</creatorcontrib><creatorcontrib>Tanvir, Imrana</creatorcontrib><creatorcontrib>Rasool, Muhammad Hidayat</creatorcontrib><creatorcontrib>Shah, Tawaf Ali</creatorcontrib><creatorcontrib>Almaary, Khalid S.</creatorcontrib><creatorcontrib>Bourhia, Mohammed</creatorcontrib><creatorcontrib>Qamar, Muhammad Usman</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>Archives of microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shafique, Muhammad</au><au>Shoaib, Iqra</au><au>Aslam, Bilal</au><au>Khalid, Rabia</au><au>Tanvir, Imrana</au><au>Rasool, Muhammad Hidayat</au><au>Shah, Tawaf Ali</au><au>Almaary, Khalid S.</au><au>Bourhia, Mohammed</au><au>Qamar, Muhammad Usman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Detection of high-risk human papillomavirus infected cervical biopsies samples by immunohistochemical expression of the p16 tumor marker</atitle><jtitle>Archives of microbiology</jtitle><stitle>Arch Microbiol</stitle><addtitle>Arch Microbiol</addtitle><date>2024-01-01</date><risdate>2024</risdate><volume>206</volume><issue>1</issue><spage>17</spage><epage>17</epage><pages>17-17</pages><artnum>17</artnum><issn>0302-8933</issn><eissn>1432-072X</eissn><abstract>Cervical cancer is the fourth most common type of cancer in women worldwide. It is widely accepted that the main cause of cervical cancer, especially in underdeveloped countries like Pakistan, is the infection caused by the human papillomavirus (HPV). The current screening and diagnostic methods face several challenges in accurately detecting the various types of lesions caused by HPV. Therefore, the present study was conducted to assess the effectiveness of p16 immunohistochemistry (IHC) analysis as a diagnostic method in samples of cervical biopsies. One hundred cervical biopsy samples were obtained from female patients across various age groups (&gt; 20– ≤ 30, &gt; 31– ≤ 40, &gt; 41– ≤ 50, &gt; 51– ≤ 60 years). These samples were subsequently prepared for subsequent examination. All samples were analyzed using automated tissue processing followed by Hematoxylin and Eosin (H &amp; E) staining, and p16 IHC tumour marker staining. The H &amp; E slides showed changes in normal cervical tissues, while four cervical abnormalities were identified statistically significant using p16 marker including chronic cervicitis, nabothian cyst formation, cervical intraepithelial neoplasia, and cervical cancers ( P value 0.014). Furthermore, among females of different age groups (&gt; 31– ≤ 40, &gt; 41– ≤ 50, &gt; 51– ≤ 60 years) were found statistically significant suffering from cervical cancer ( P value 0.04), HPV with cervical cancer ( P value 0.01), HPV with cervical intraepithelial neoplasia ( P value 0.01). Based on the available data, it can be inferred that the incorporation of the p16 tumor marker may be a valuable method for detecting high-risk HPV in cervical biopsies samples.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>38085340</pmid><doi>10.1007/s00203-023-03736-0</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0302-8933
ispartof Archives of microbiology, 2024-01, Vol.206 (1), p.17-17, Article 17
issn 0302-8933
1432-072X
language eng
recordid cdi_proquest_miscellaneous_3153568148
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Abnormalities
Adult
Age groups
automation
Biochemistry
Biomarkers
Biomarkers, Tumor - analysis
Biomarkers, Tumor - metabolism
Biomedical and Life Sciences
Biopsy
Biotechnology
Cancer
Cell Biology
Cervical cancer
Cervicitis
Developing countries
Diagnostic systems
diagnostic techniques
Ecology
eosin
Female
Females
Human papillomavirus
Human Papillomavirus Viruses
Humans
Immunohistochemistry
LDCs
Life Sciences
Microbial Ecology
Microbiology
Middle Aged
Original Paper
Pakistan
Papillomaviridae
Papillomavirus Infections - diagnosis
Papillomavirus Infections - pathology
Samples
Staining
Statistical analysis
Tumor markers
Tumors
Uterine Cervical Dysplasia - diagnosis
Uterine Cervical Dysplasia - pathology
uterine cervical neoplasms
Uterine Cervical Neoplasms - diagnosis
Uterine Cervical Neoplasms - pathology
Young Adult
title Detection of high-risk human papillomavirus infected cervical biopsies samples by immunohistochemical expression of the p16 tumor marker
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T22%3A13%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Detection%20of%20high-risk%20human%20papillomavirus%20infected%20cervical%20biopsies%20samples%20by%20immunohistochemical%20expression%20of%20the%20p16%20tumor%20marker&rft.jtitle=Archives%20of%20microbiology&rft.au=Shafique,%20Muhammad&rft.date=2024-01-01&rft.volume=206&rft.issue=1&rft.spage=17&rft.epage=17&rft.pages=17-17&rft.artnum=17&rft.issn=0302-8933&rft.eissn=1432-072X&rft_id=info:doi/10.1007/s00203-023-03736-0&rft_dat=%3Cproquest_cross%3E2902934415%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2900773620&rft_id=info:pmid/38085340&rfr_iscdi=true